Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

859.80INR
1 Apr 2015
Change (% chg)

-- (--)
Prev Close
Rs859.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
798,378
52-wk High
Rs869.70
52-wk Low
Rs429.05

RANB.NS

Chart for RANB.NS

About

Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and... (more)

Overall

Beta: 0.47
Market Cap(Mil.): Rs365,985.50
Shares Outstanding(Mil.): 425.66
Dividend: --
Yield (%): --

Financials

  RANB.NS Industry Sector
P/E (TTM): -- 41.06 41.71
EPS (TTM): -19.13 -- --
ROI: -- 16.86 16.20
ROE: -- 17.36 17.00
Search Stocks

BUZZ-Japan's Daiichi Sankyo gains on stake sale in Sun Pharma

** Daiichi Sankyo Co Ltd shares rise 2.6 pct after the company said it was selling a part or all of its stake in Indian drugmaker Sun Pharmaceutical Industries Ltd

21 Apr 2015

Sensex rises over 1 percent, posts first weekly gain in four

MUMBAI - The BSE Sensex and Nifty rose on Wednesday, posting their first weekly gain in four and the biggest since Jan. 23 week, as lenders rallied ahead of the Reserve Bank of India's policy review, while Sun Pharmaceutical Industries and Ranbaxy Laboratories surged ahead of a planned merger.

01 Apr 2015

Indian shares rise over 1 pct, post first weekly gain in 4

MUMBAI, April 1 - Indian shares rose on Wednesday, posting their first weekly gain in four and the biggest since Jan. 23 week, as banks rallied ahead of the central bank's policy review, while Sun Pharmaceutical Industries and Ranbaxy Laboratories surged ahead of a planned merger.

01 Apr 2015

Indian shares set to snap 3-week losing streak; drug makers rise

MUMBAI, April 1 - Indian shares rose on Wednesday, on track to snap a three-week losing streak, led by gains in pharmaceutical stocks such as Sun Pharmaceutical Industries and Ranbaxy Laboratories ahead of the latter's amalgamation with the former.

01 Apr 2015

BUZZ-India's Ranbaxy hits record high before amalgamation with Sun Pharma

** Ranbaxy Laboratories Ltd rises as much as 5.1 pct to hit an all-time high

01 Apr 2015

Sun Pharma open to large acquisitions post Ranbaxy

MUMBAI - India's largest drugmaker Sun Pharmaceutical Industries Ltd will look at making more large acquisitions even as it winds up a $3.2 billion deal to buy smaller rival Ranbaxy Laboratories Ltd.

25 Mar 2015

UPDATE 1-India's Sun Pharma open to large acquisitions post Ranbaxy deal

* To boost annual R&D spending to about $300 mln (Adds managing director comments)

25 Mar 2015

Indian shares edge down in cautious trade; Sun Pharma rises

MUMBAI, March 25 - Indian shares edged down on Wednesday to their near six-week lows and were heading for a sixth straight session of falls, as caution ahead of the expiry of monthly derivatives and the end of the fiscal year hit blue-chips such as Larsen & Toubro.

25 Mar 2015

India's Sun Pharma open to large acquisitions post Ranbaxy deal

MUMBAI, March 25 - Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Wednesday its $3.2 billion acquisition of smaller rival Ranbaxy Laboratories Ltd will not restrict it from making further large acquisitions.

25 Mar 2015

BUZZ-Investors take tactical refuge in Indian pharma ahead of Fed

** Pharmaceutical stocks, traditionally seen as defensives, gain on churning ahead of the U.S. Federal Reserve policy meeting outcome on Wednesday

17 Mar 2015

Earnings vs. Estimates

Search Stocks